164 related articles for article (PubMed ID: 23108119)
1. Prevention of Barrett esophagus and esophageal adenocarcinoma by smoothened inhibitor in a rat model of gastroesophageal reflux disease.
Gibson MK; Zaidi AH; Davison JM; Sanz AF; Hough B; Komatsu Y; Kosovec JE; Bhatt A; Malhotra U; Foxwell T; Rotoloni CL; Hoppo T; Jobe BA
Ann Surg; 2013 Jul; 258(1):82-8. PubMed ID: 23108119
[TBL] [Abstract][Full Text] [Related]
2. Suitability of surgically induced chronic reflux in rats for studying esophageal carcinogenesis.
Gronnier C; Piessen G; Leteurtre E; Van Seuningen I; Mariette C
Ann Surg; 2015 May; 261(5):e140-1. PubMed ID: 24374550
[No Abstract] [Full Text] [Related]
3. Reply to letter: "surgically induced rat reflux model ideal for study of esophageal carcinogenesis".
Jobe BA; Zaidi AH
Ann Surg; 2015 May; 261(5):e141-2. PubMed ID: 24424138
[No Abstract] [Full Text] [Related]
4. High yield reproducible rat model recapitulating human Barrett's carcinogenesis.
Matsui D; Omstead AN; Kosovec JE; Komatsu Y; Lloyd EJ; Raphael H; Kelly RJ; Zaidi AH; Jobe BA
World J Gastroenterol; 2017 Sep; 23(33):6077-6087. PubMed ID: 28970723
[TBL] [Abstract][Full Text] [Related]
5. Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats.
Kumagai H; Mukaisho K; Sugihara H; Miwa K; Yamamoto G; Hattori T
Carcinogenesis; 2004 May; 25(5):723-7. PubMed ID: 14754873
[TBL] [Abstract][Full Text] [Related]
6. Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.
Chu YX; Wang WH; Dai Y; Teng GG; Wang SJ
World J Gastroenterol; 2014 Nov; 20(42):15715-26. PubMed ID: 25400455
[TBL] [Abstract][Full Text] [Related]
7. Influence of surgically induced gastric and gastroduodenal content reflux on esophageal carcinogenesis--experimental model in Wistar female rats.
Melo LL; Kruel CD; Kliemann LM; Cavazzola LT; Boeno Rda L; Silber PC; Grossi RS
Dis Esophagus; 1999; 12(2):106-15. PubMed ID: 10466042
[TBL] [Abstract][Full Text] [Related]
8. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.
Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N
Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392
[TBL] [Abstract][Full Text] [Related]
9. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen.
Goldstein SR; Yang GY; Curtis SK; Reuhl KR; Liu BC; Mirvish SS; Newmark HL; Yang CS
Carcinogenesis; 1997 Nov; 18(11):2265-70. PubMed ID: 9395230
[TBL] [Abstract][Full Text] [Related]
10. Oxidative damage in an esophageal adenocarcinoma model with rats.
Chen X; Ding YW; Yang Gy; Bondoc F; Lee MJ; Yang CS
Carcinogenesis; 2000 Feb; 21(2):257-63. PubMed ID: 10657966
[TBL] [Abstract][Full Text] [Related]
11. Gene expression in rats with Barrett's esophagus and esophageal adenocarcinoma induced by gastroduodenoesophageal reflux.
Cheng P; Gong J; Wang T; Chen J; Liu GS; Zhang R
World J Gastroenterol; 2005 Sep; 11(33):5117-22. PubMed ID: 16127739
[TBL] [Abstract][Full Text] [Related]
12. Barrett's esophagus and esophageal adenocarcinoma in adults: long-term GERD or something else?
Pondugula K; Wani S; Sharma P
Curr Gastroenterol Rep; 2007 Dec; 9(6):468-74. PubMed ID: 18377797
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Hedgehog Pathway Using Itraconazole to Prevent Progression of Barrett's Esophagus to Invasive Esophageal Adenocarcinoma.
Kelly RJ; Ansari AM; Miyashita T; Zahurak M; Lay F; Ahmed AK; Born LJ; Pezhouh MK; Salimian KJ; Ng C; Matsangos AE; Stricker-Krongrad AH; Mukaisho KI; Marti GP; Chung CH; Canto MI; Rudek MA; Meltzer SJ; Harmon JW
Ann Surg; 2021 Jun; 273(6):e206-e213. PubMed ID: 31290765
[TBL] [Abstract][Full Text] [Related]
14. Esophageal adenocarcinoma arising after antireflux surgery: a population-based analysis.
Kauttu TM; Rantanen TK; Sihvo EI; Räsänen JV; Puolakkainen P; Salo JA
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1450-4; discussion 1454. PubMed ID: 21546258
[TBL] [Abstract][Full Text] [Related]
15. [A COX-2 inhibitor suppresses esophageal inflammation-metaplasia-adenocarcinoma sequence in rats].
Miwa K; Oyama K; Fujimura T
Nihon Rinsho; 2005 Aug; 63(8):1387-93. PubMed ID: 16101227
[TBL] [Abstract][Full Text] [Related]
16. Smoothened inhibition leads to decreased proliferation and induces apoptosis in esophageal adenocarcinoma cells.
Zaidi AH; Komatsu Y; Kelly LA; Malhotra U; Rotoloni C; Kosovec JE; Zahoor H; Makielski R; Bhatt A; Hoppo T; Jobe BA
Cancer Invest; 2013 Aug; 31(7):480-9. PubMed ID: 23915072
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus.
Buttar NS; Wang KK; Leontovich O; Westcott JY; Pacifico RJ; Anderson MA; Krishnadath KK; Lutzke LS; Burgart LJ
Gastroenterology; 2002 Apr; 122(4):1101-12. PubMed ID: 11910360
[TBL] [Abstract][Full Text] [Related]
18. Serial Endoscopic Evaluation of Esophageal Disease in a Cancer Model: A Paradigm Shift for Esophageal Adenocarcinoma (EAC) Drug Discovery and Development.
Omstead AN; Kosovec JE; Matsui D; Martin SA; Smith MA; Aaron Guel D; Kolano J; Komatsu Y; Habib F; Lai C; Christopher K; Kelly RJ; Zaidi AH; Jobe BA
Cancer Invest; 2018; 36(7):363-370. PubMed ID: 30142016
[TBL] [Abstract][Full Text] [Related]
19. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.
Chang JT; Katzka DA
Arch Intern Med; 2004 Jul; 164(14):1482-8. PubMed ID: 15277277
[TBL] [Abstract][Full Text] [Related]
20. [An experimental study on chemoprevention of esophageal adenocarcinoma by celecoxib, a selective cyclooxygenase-2 inhibitor].
Zhang T; Su LW; Zhu YF; Lang HJ; Zhang F; Zhou YA; Liang XH; Wang YJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 May; 15(5):512-6. PubMed ID: 22648851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
